A Study of ARQ 171 in Patients With Advanced Solid Tumors

NCT00398840 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

14

Enrollment

INDUSTRY

Sponsor class

Conditions

Cancer

Interventions

DRUG: ARQ 171

Sponsor

ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)